Literature DB >> 1081376

Eosinophil-specific and other granulocyte-specific antinuclear antibodies in juvenile chronic polyarthritis and adult rheumatoid arthritis.

J N Rosenberg, G D Johnson, E J Holborow, E G Bywaters.   

Abstract

Sera from 151 children of whom 112 had juvenile chronic polyarthritis (JCP), and from adults with rheumatoid arthritis (RA), and from healthy pregnant females were tested for the presence of granulocyte-specific antinuclear antibodies (GS-ANA). These were detected in 20% of sera from cases of JCP, in 68% of adult RA, but in none of the controls. Eosinophil-specific ANA were the only ANA present in 18% of positive children and 54% of the positive adults. GS-ANA in children were predominantly IgG and of low titre. Heat-stable GS-ANA were detected in sera from eight children but none bound complement. The presence of GS-ANA was not significantly associated with sex, age of onset, duration of disease, mean active joint count, mean ESR, nor with the presence of fever, rash, splenomegaly, amyloidosis, pericarditis, or rheumatoid factor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081376      PMCID: PMC1006426          DOI: 10.1136/ard.34.4.350

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  AN ANTINUCLEAR FACTOR SPECIFIC FOR LEUCOCYTES.

Authors:  V FABER; P ELLING; G NORUP; B MANSA; N I NISSEN
Journal:  Lancet       Date:  1964-08-15       Impact factor: 79.321

2.  ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

Authors:  D J WARD; G D JOHNSON; E J HOLBOROW
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

3.  GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA.

Authors:  E V BARNETT; J J CONDEMI; J P LEDDY; J H VAUGHAN
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

4.  Incidence of the anti-nuclear factor in human sera.

Authors:  W R ALEXANDER; J M BREMNER; J J DUTHIE
Journal:  Ann Rheum Dis       Date:  1960-12       Impact factor: 19.103

5.  Prognosis in Still's disease.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Bull Rheum Dis       Date:  1959-05

6.  Anti-IgG and antinuclear antibodies in juvenile rheumatoid arthritis.

Authors:  E Munthe
Journal:  Scand J Rheumatol       Date:  1972       Impact factor: 3.641

7.  Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors.

Authors:  A Wiik; E Munthe
Journal:  Immunology       Date:  1972-07       Impact factor: 7.397

8.  Multispot immunofluorescence: a simple semi-automatic method of processing large numbers of tests.

Authors:  P O'Neill; G D Johnson
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411

9.  Juvenile rheumatoid arthritis--a serologic survey of 200 consecutive patients.

Authors:  R Bluestone; L S Goldberg; R M Katz; J M Marchesano; J J Calabro
Journal:  J Pediatr       Date:  1970-07       Impact factor: 4.406

10.  The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease).

Authors:  J G Schaller; G D Johnson; E J Holborow; B M Ansell; W K Smiley
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug
View more
  2 in total

1.  Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Authors:  J N Rosenberg; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

2.  Autoimmune liver disease-related autoantibodies in patients with biliary atresia.

Authors:  Shu-Yin Pang; Yu-Mei Dai; Rui-Zhong Zhang; Yi-Hao Chen; Xiao-Fang Peng; Jie Fu; Zheng-Rong Chen; Yun-Feng Liu; Li-Yuan Yang; Zhe Wen; Jia-Kang Yu; Hai-Ying Liu
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.